Nabla Copilot
by Nabla Technologies
Nabla Copilot is an AI assistant for clinicians that generates structured clinical notes from patient encounters and supports documentation workflows, with integrations for electronic health record systems.
Why Abandoned
Nabla continues to market Copilot on its official website and announced a $70 million Series C financing in June 2025 to expand the clinical AI assistant.
🩺 Health Signals
- HTTP Status
- 200
- Response
- —
- SSL
- —
- Confidence
- 96%
- Domain expires
- —
- Last content change
- —
- Last tweet
- —
- API status
- —
📅 Timeline
Nabla Copilot launched
Nabla introduced Copilot as a GPT-3-powered digital assistant designed to help physicians generate clinical notes from consultations.
Nabla raised $24 million in Series B funding
Nabla announced a Series B round led by Cathay Innovation, with participation from ZEBOX Ventures and existing investors.
Nabla raised $70 million in Series C funding
Nabla announced a Series C led by HV Capital, with participation from Highland Europe, DST Global, and Cathay Innovation, to expand its clinical AI platform.
🔄 Alternatives to Nabla Copilot
Fireflies.ai
🟢ActiveAI notetaker that automatically records, transcribes, and analyzes voice conversations.
Microsoft Copilot
🟢ActiveMicrosoft Copilot is a generative AI assistant available on the web, Windows, mobile devices, and Microsoft Edge. It answers questions, drafts and summarizes text, creates images, and can connect with Microsoft services.
Otter.ai
🟢ActiveAI meeting assistant that records, transcribes, and summarizes meetings in real-time.
Zoom AI Companion
🟢ActiveZoom AI Companion is a generative AI assistant built into Zoom Workplace. It can summarize meetings, identify action items, help draft chat and email messages, and answer questions using permitted workplace context.
🪦 Other dead Healthcare tools
Kheiron Mia
🟡Acquired / MergedMia is Kheiron Medical Technologies’ artificial intelligence platform for breast-screening mammography. It supports radiologists by analyzing mammograms and identifying cases that may warrant further review.
MaxQ AI ACCIPIO
🟠Possibly DeadACCIPIO was MaxQ AI's clinical AI platform for analyzing non-contrast head CT scans and prioritizing suspected intracranial hemorrhage cases for radiologist review. It was a triage aid, not a standalone diagnosis system.
Arterys Cardio AI
🟡Acquired / MergedCloud-based cardiac MRI analysis software that used machine learning to assist clinicians with image segmentation, ventricular measurements, and cardiac function assessment. Tempus acquired Arterys in 2022.
Zebra Medical Vision Imaging Analytics
🟡Acquired / MergedAI-based medical imaging analytics developed by Zebra Medical Vision to help identify findings in radiology scans. Nanox acquired Zebra in 2021 and incorporated its software into the Nanox.AI portfolio.
❓ Frequently Asked Questions
What is Nabla Copilot?
Nabla Copilot is an ambient AI assistant for healthcare professionals. It listens during patient encounters, with appropriate consent and workflow controls, and drafts structured clinical documentation for clinician review.
How does Nabla Copilot work for clinical notes?
It captures the clinical conversation and converts relevant information into a draft note, which the clinician can review, edit, and transfer into the electronic health record.
Does Nabla Copilot integrate with electronic health records?
Yes. Nabla offers EHR integrations and workflow options, although availability and implementation details depend on the healthcare organization and its systems.
Is Nabla Copilot still active?
Yes. Nabla continues to offer Copilot through its official website, and its June 2025 Series C announcement described ongoing deployment and expansion.
Who founded Nabla and when did Nabla Copilot launch?
Nabla was founded by Alexandre Lebrun, Delphine Groll, and Martin Raison. The company publicly introduced Nabla Copilot on March 14, 2023.